Lifestyle management to prevent and treat atrial fibrillation

References

• Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study. Circulation. 2014;129(8):837–847.
   PubMed Web of Science ®Google Scholar
• Wong CX, Brooks AG, Leong DP, et al. The increasing burden of atrial fibrillation compared with heart failure and myocardial infarction: a 15-year study of all hospitalizations in Australia. Arch Intern Med. 2012;172(9):739–741.
   PubMedGoogle Scholar
• Wong CX, Lau DH, Sanders P. Atrial fibrillation epidemic and hospitalizations: how to turn the rising tide? Circulation. 2014;129(23):2361–2363.
   PubMed Web of Science ®Google Scholar
• Ganesan AN, Shipp NJ, Brooks AG, et al. Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis. J Am Heart Assoc. 2013;2(2):e004549.
   PubMed Web of Science ®Google Scholar
• Gupta A, Perera T, Ganesan A, et al. Complications of catheter ablation of atrial fibrillation: a systematic review. Circ Arrhythm Electrophysiol. 2013;6(6):1082–1088.
   PubMed Web of Science ®Google Scholar
• Huxley RR, Lopez FL, Folsom AR, et al. Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the atherosclerosis risk in communities (ARIC) study. Circulation. 2011;123(14):1501–1508.
   PubMed Web of Science ®Google Scholar
• Linz D, Linz B, Hohl M, et al. Atrial arrhythmogenesis in obstructive sleep apnea: therapeutic implications. Sleep Med Rev. 2015;26:87–94.
   PubMed Web of Science ®Google Scholar
• Mitchell GF, Vasan RS, Keyes MJ, et al. Pulse pressure and risk of new-onset atrial fibrillation. JAMA. 2007;297(7):709–715.
   PubMed Web of Science ®Google Scholar
• Lau DH, Middeldorp ME, Brooks AG, et al. Aortic stiffness in lone atrial fibrillation: a novel risk factor for arrhythmia recurrence. Plos one. 2013;8(10):e76776.
   PubMed Web of Science ®Google Scholar
• Chamberlain AM, Agarwal SK, Ambrose M, et al. Metabolic syndrome and incidence of atrial fibrillation among blacks and whites in the atherosclerosis risk in communities (ARIC) study. Am Heart J. 2010;159(5):850–856.
   PubMed Web of Science ®Google Scholar
• Nabauer M, Gerth A, Limbourg T, et al. The registry of the German competence NETwork on atrial fibrillation: patient characteristics and initial management. Europace. 2009;11(4):423–434.
   PubMed Web of Science ®Google Scholar
• Teh AW, Kistler PM, Lee G, et al. Long-term effects of catheter ablation for lone atrial fibrillation: progressive atrial electroanatomic substrate remodeling despite successful ablation. Heart Rhythm. 2012;9(4):473–480.
   PubMed Web of Science ®Google Scholar
• January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American college of cardiology/American heart association task force on practice guidelines and the heart rhythm society. Circulation. 2014;130(23):e199–e267.
   PubMed Web of Science ®Google Scholar
• European Heart Rhythm A, European Association for Cardio-Thoracic S, et al. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European society of cardiology (ESC). Eur Heart J. 2010;31(19):2369–2429.
   PubMed Web of Science ®Google Scholar
• Abed HS, Wittert GA, Leong DP, et al. Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial. JAMA. 2013;310(19):2050–2060.
   PubMed Web of Science ®Google Scholar
• Pathak RK, Middeldorp ME, Lau DH, et al. Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study. J Am Coll Cardiol. 2014;64(21):2222–2231.
   PubMed Web of Science ®Google Scholar
• Lau DH, Schotten U, Mahajan R, et al. Novel mechanisms in the pathogenesis of atrial fibrillation: practical applications. Eur Heart J. 2015 Nov 17. doi:10.1093.
   PubMed Web of Science ®Google Scholar
• Manolis AJ, Rosei EA, Coca A, et al. Hypertension and atrial fibrillation: diagnostic approach, prevention and treatment. Position paper of the working group ‘Hypertension arrhythmias and thrombosis’ of the European society of hypertension. J Hypertens. 2012;30(2):239–252.
   PubMed Web of Science ®Google Scholar
• Kannel WB, Wolf PA, Benjamin EJ, et al. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol. 1998;82(8A):2N–9N.
   PubMed Web of Science ®Google Scholar
• Perez MV, Wang PJ, Larson JC, et al. Risk factors for atrial fibrillation and their population burden in postmenopausal women: the women’s health initiative observational study. Heart. 2013;99(16):1173–1178.
   PubMed Web of Science ®Google Scholar
• Conen D, Tedrow UB, Koplan BA, et al. Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women. Circulation. 2009;119(16):2146–2152.
   PubMed Web of Science ®Google Scholar
• Lau DH, Mackenzie L, Kelly DJ, et al. Hypertension and atrial fibrillation: evidence of progressive atrial remodeling with electrostructural correlate in a conscious chronically instrumented ovine model. Heart Rhythm. 2010;7(9):1282–1290.
   PubMed Web of Science ®Google Scholar
• Lau DH, Mackenzie L, Kelly DJ, et al. Short-term hypertension is associated with the development of atrial fibrillation substrate: a study in an ovine hypertensive model. Heart Rhythm. 2010;7(3):396–404.
   PubMed Web of Science ®Google Scholar
• Lau DH, Shipp NJ, Kelly DJ, et al. Atrial arrhythmia in ageing spontaneously hypertensive rats: unraveling the substrate in hypertension and ageing. Plos one. 2013;8(8):e72416.
   PubMed Web of Science ®Google Scholar
• Matsuyama N, Tsutsumi T, Kubota N, et al. Direct action of an angiotensin II receptor blocker on angiotensin II-induced left atrial conduction delay in spontaneously hypertensive rats. Hypertens Res. 2009;32(8):721–726.
   PubMed Web of Science ®Google Scholar
• Thanigaimani S, Lau DH, Brooks AG, et al. Tranilast prevents hypertensive atrial electrical and structural remodeling independent of systolic blood pressure level: a comparative study with blood pressure lowering therapies. Circulation. 2014;130:A18013.
   Google Scholar
• Zhao D, Wang ZM, Wang LS. Prevention of atrial fibrillation with renin-angiotensin system inhibitors on essential hypertensive patients: a meta-analysis of randomized controlled trials. J Biomed Res. 2015;29(6):475–485.
   PubMed Web of Science ®Google Scholar
• Badheka AO, Patel NJ, Grover PM, et al. Optimal blood pressure in patients with atrial fibrillation (from the AFFIRM Trial). Am J Cardiol. 2014;114(5):727–736.
   PubMed Web of Science ®Google Scholar
• Rao MP, Halvorsen S, Wojdyla D, et al. Blood pressure control and risk of stroke or systemic embolism in patients with atrial fibrillation: results from the apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) Trial. J Am Heart Assoc. 2015;4.doi:10.1161.
   Google Scholar
• Group SR, Wright JT Jr., Williamson JD, et al. A Randomized Trial of Intensive versus standard blood-pressure control. N Engl J Med. 2015;373(22):2103–2116.
   PubMed Web of Science ®Google Scholar
• Ettehad D, Emdin CA, Kiran A, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2015;387(10022):957–967.
   PubMed Web of Science ®Google Scholar
• Schnabel RB, Yin X, Gona P, et al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham heart study: a cohort study. Lancet. 2015;386(9989):154–162.
   PubMed Web of Science ®Google Scholar
• Frost L, Hune LJ, Vestergaard P. Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish diet, cancer, and health study. Am J Med. 2005;118(5):489–495.
   PubMed Web of Science ®Google Scholar
• Smith JG, Platonov PG, Hedblad B, et al. Atrial fibrillation in the Malmo diet and cancer study: a study of occurrence, risk factors and diagnostic validity. Eur J Epidemiol. 2010;25(2):95–102.
   PubMed Web of Science ®Google Scholar
• Tedrow UB, Conen D, Ridker PM, et al. The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (women’s health study). J Am Coll Cardiol. 2010;55(21):2319–2327.
   PubMed Web of Science ®Google Scholar
• Wong CX, Sullivan T, Sun MT, et al. Obesity and the risk of incident, post-operative, and post-ablation atrial fibrillation. JACC: Clinical Electrophysiology. 2015;1(3):139–152.
   PubMedGoogle Scholar
• Munger TM, Dong YX, Masaki M, et al. Electrophysiological and hemodynamic characteristics associated with obesity in patients with atrial fibrillation. J Am Coll Cardiol. 2012;60(9):851–860.
   PubMed Web of Science ®Google Scholar
• Abed HS, Samuel CS, Lau DH, et al. Obesity results in progressive atrial structural and electrical remodeling: implications for atrial fibrillation. Heart Rhythm. 2013;10(1):90–100.
   PubMed Web of Science ®Google Scholar
• Mahajan R, Lau DH, Brooks AG, et al. Electrophysiological, electroanatomical, and structural remodeling of the atria as consequences of sustained obesity. J Am Coll Cardiol. 2015;66(1):1–11.
   PubMed Web of Science ®Google Scholar
• Venteclef N, Guglielmi V, Balse E, et al. Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipo-fibrokines. Eur Heart J. 2015;36(13): 795–805a.
   PubMed Web of Science ®Google Scholar
• Wong CX, Abed HS, Molaee P, et al. Pericardial fat is associated with atrial fibrillation severity and ablation outcome. J Am Coll Cardiol. 2011;57(17):1745–1751.
   PubMed Web of Science ®Google Scholar
• Batal O, Schoenhagen P, Shao M, et al. Left atrial epicardial adiposity and atrial fibrillation. Circ Arrhythm Electrophysiol. 2010;3(3):230–236.
   PubMed Web of Science ®Google Scholar
• Gami AS, Hodge DO, Herges RM, et al. Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol. 2007;49(5):565–571.
   PubMed Web of Science ®Google Scholar
• Mahajan R, Lau DH, Sanders P. Impact of obesity on cardiac metabolism, fibrosis, and function. Trends Cardiovasc Med. 2015;25(2):119–126.
   PubMed Web of Science ®Google Scholar
• Pathak RK, Mahajan R, Lau DH, et al. The implications of obesity for cardiac arrhythmia mechanisms and management. Can J Cardiol. 2015;31(2):203–210.
   PubMed Web of Science ®Google Scholar
• Pathak RK, Middeldorp ME, Meredith M, et al. Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY). J Am Coll Cardiol. 2015;65(20):2159–2169.
   PubMed Web of Science ®Google Scholar
• Mahajan R, Brooks AG, Shipp N, et al. AF and obesity: Impact of weight reduction on the atrial substrate. Heart Rhythm. 2013;10:S484.
   Google Scholar
• Gami AS, Pressman G, Caples SM, et al. Association of atrial fibrillation and obstructive sleep apnea. Circulation. 2004;110(4):364–367.
   PubMed Web of Science ®Google Scholar
• Stevenson IH, Teichtahl H, Cunnington D, et al. Prevalence of sleep disordered breathing in paroxysmal and persistent atrial fibrillation patients with normal left ventricular function. Eur Heart J. 2008;29(13):1662–1669.
   PubMed Web of Science ®Google Scholar
• Monahan K, Brewster J, Wang L, et al. Relation of the severity of obstructive sleep apnea in response to anti-arrhythmic drugs in patients with atrial fibrillation or atrial flutter. Am J Cardiol. 2012;110(3):369–372.
   PubMed Web of Science ®Google Scholar
• Kanagala R, Murali NS, Friedman PA, et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation. 2003;107(20):2589–2594.
   PubMed Web of Science ®Google Scholar
• Ng CY, Liu T, Shehata M, et al. Meta-analysis of obstructive sleep apnea as predictor of atrial fibrillation recurrence after catheter ablation. Am J Cardiol. 2011;108(1):47–51.
   PubMed Web of Science ®Google Scholar
• Yaranov DM, Smyrlis A, Usatii N, et al. Effect of obstructive sleep apnea on frequency of stroke in patients with atrial fibrillation. Am J Cardiol. 2015;115(4):461–465.
   PubMed Web of Science ®Google Scholar
• Dimitri H, Ng M, Brooks AG, et al. Atrial remodeling in obstructive sleep apnea: implications for atrial fibrillation. Heart Rhythm. 2012;9(3):321–327.
   PubMed Web of Science ®Google Scholar
• Iwasaki YK, Kato T, Xiong F, et al. Atrial fibrillation promotion with long-term repetitive obstructive sleep apnea in a rat model. J Am Coll Cardiol. 2014;64(19):2013–2023.
   PubMed Web of Science ®Google Scholar
• Fein AS, Shvilkin A, Shah D, et al. Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation. J Am Coll Cardiol. 2013;62(4):300–305.
   PubMed Web of Science ®Google Scholar
• Albuquerque FN, Calvin AD, Sert Kuniyoshi FH, et al. Sleep-disordered breathing and excessive daytime sleepiness in patients with atrial fibrillation. Chest. 2012;141(4):967–973.
   PubMed Web of Science ®Google Scholar
• Kodama S, Saito K, Tanaka S, et al. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis. JAMA. 2009;301(19):2024–2035.
   PubMed Web of Science ®Google Scholar
• Qureshi WT, Alirhayim Z, Blaha MJ, et al. Cardiorespiratory fitness and risk of incident atrial fibrillation: results from the henry ford exercise testing (FIT) project. Circulation. 2015;131(21):1827–1834.
   PubMed Web of Science ®Google Scholar
• Mozaffarian D, Furberg CD, Psaty BM, et al. Physical activity and incidence of atrial fibrillation in older adults: the cardiovascular health study. Circulation. 2008;118(8):800–807.
   PubMed Web of Science ®Google Scholar
• Elliott AD, Mahajan R, Pathak RK, et al. Exercise training and atrial fibrillation: further evidence for the importance of lifestyle change. Circulation. 2016;133(5):457–459.
   PubMed Web of Science ®Google Scholar
• Hegbom F, Stavem K, Sire S, et al. Effects of short-term exercise training on symptoms and quality of life in patients with chronic atrial fibrillation. Int J Cardiol. 2007;116(1):86–92.
   PubMed Web of Science ®Google Scholar
• Osbak PS, Mourier M, Kjaer A, et al. A randomized study of the effects of exercise training on patients with atrial fibrillation. Am Heart J. 2011;162(6):1080–1087.
   PubMed Web of Science ®Google Scholar
• Pathak RK, Elliott A, Middeldorp ME, et al. Impact of CARDIOrespiratory FITness on arrhythmia recurrence in obese individuals with atrial fibrillation: the CARDIO-FIT study. J Am Coll Cardiol. 2015;66(9):985–996.
   PubMed Web of Science ®Google Scholar
• Malmo V, Nes BM, Amundsen BH, et al. Aerobic interval training reduces the burden of atrial fibrillation in the short term: a randomized trial. Circulation. 2016;133(5):466–473.
   PubMed Web of Science ®Google Scholar
• Huxley RR, Filion KB, Konety S, et al. Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation. Am J Cardiol. 2011;108(1):56–62.
   PubMed Web of Science ®Google Scholar
• Dublin S, Glazer NL, Smith NL, et al. Diabetes mellitus, glycemic control, and risk of atrial fibrillation. J Gen Intern Med. 2010;25(8):853–858.
   PubMed Web of Science ®Google Scholar
• Fatemi O, Yuriditsky E, Tsioufis C, et al. Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the action to control cardiovascular risk in diabetes study). Am J Cardiol. 2014;114(8):1217–1222.
   PubMed Web of Science ®Google Scholar
• Du X, Ninomiya T, De Galan B, et al. Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study. Eur Heart J. 2009;30(9):1128–1135.
   PubMed Web of Science ®Google Scholar
• Goudis CA, Korantzopoulos P, Ntalas IV, et al. Diabetes mellitus and atrial fibrillation: pathophysiological mechanisms and potential upstream therapies. Int J Cardiol. 2015;184:617–622.
   PubMed Web of Science ®Google Scholar
• Kato T, Yamashita T, Sekiguchi A, et al. What are arrhythmogenic substrates in diabetic rat atria? J Cardiovasc Electrophysiol. 2006;17(8):890–894.
   PubMed Web of Science ®Google Scholar
• Fu H, Liu C, Li J, et al. Impaired atrial electromechanical function and atrial fibrillation promotion in alloxan-induced diabetic rabbits. Cardiol J. 2013;20(1):59–67.
   PubMed Web of Science ®Google Scholar
• Saliba W, Barnett-Griness O, Elias M, et al. Glycated hemoglobin and risk of first episode stroke in diabetic patients with atrial fibrillation: a cohort study. Heart Rhythm. 2015;12(5):886–892.
   PubMed Web of Science ®Google Scholar
• Ashburner JM, Go AS, Chang Y, et al. Effect of diabetes and glycemic control on ischemic stroke risk in AF patients: ATRIA study. J Am Coll Cardiol. 2016;67(3):239–247.
   PubMed Web of Science ®Google Scholar
• Fox CS, Golden SH, Anderson C, et al. Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: a scientific statement from the American heart association and the American diabetes association. Diabetes Care. 2015;38(9):1777–1803.
   PubMed Web of Science ®Google Scholar
• Lopez FL, Agarwal SK, Maclehose RF, et al. Blood lipid levels, lipid-lowering medications, and the incidence of atrial fibrillation: the atherosclerosis risk in communities study. Circ Arrhythm Electrophysiol. 2012;5(1):155–162.
   PubMed Web of Science ®Google Scholar
• Psaty BM, Manolio TA, Kuller LH, et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation. 1997;96(7):2455–2461.
   PubMed Web of Science ®Google Scholar
• Mora S, Akinkuolie AO, Sandhu RK, et al. Paradoxical association of lipoprotein measures with incident atrial fibrillation. Circ Arrhythm Electrophysiol. 2014;7(4):612–619.
   PubMed Web of Science ®Google Scholar
• Watanabe H, Tanabe N, Yagihara N, et al. Association between lipid profile and risk of atrial fibrillation. Circ J. 2011;75(12):2767–2774.
   PubMed Web of Science ®Google Scholar
• Alonso A, Yin X, Roetker NS, et al. Blood lipids and the incidence of atrial fibrillation: the multi-ethnic study of atherosclerosis and the Framingham heart study. J Am Heart Assoc. 2014;3(5):e001211.
   Google Scholar
• Haywood LJ, Ford CE, Crow RS, et al. Atrial fibrillation at baseline and during follow-up in ALLHAT (Antihypertensive and lipid-lowering treatment to prevent heart attack trial). J Am Coll Cardiol. 2009;54(22):2023–2031.
   PubMed Web of Science ®Google Scholar
• Fang WT, Li HJ, Zhang H, et al. The role of statin therapy in the prevention of atrial fibrillation: a meta-analysis of randomized controlled trials. Br J Clin Pharmacol. 2012;74(5):744–756.
   PubMed Web of Science ®Google Scholar
• Fauchier L, Clementy N, Babuty D. Statin therapy and atrial fibrillation: systematic review and updated meta-analysis of published randomized controlled trials. Curr Opin Cardiol. 2013;28(1):7–18.
   PubMed Web of Science ®Google Scholar
• Sicouri S, Gianetti B, Zygmunt AC, et al. Antiarrhythmic effects of simvastatin in canine pulmonary vein sleeve preparations. J Am Coll Cardiol. 2011;57(8):986–993.
   PubMed Web of Science ®Google Scholar
• Shiroshita-Takeshita A, Schram G, Lavoie J, et al. Effect of simvastatin and antioxidant vitamins on atrial fibrillation promotion by atrial-tachycardia remodeling in dogs. Circulation. 2004;110(16):2313–2319.
   PubMed Web of Science ®Google Scholar
• Shiroshita-Takeshita A, Brundel BJ, Burstein B, et al. Effects of simvastatin on the development of the atrial fibrillation substrate in dogs with congestive heart failure. Cardiovasc Res. 2007;74(1):75–84.
   PubMed Web of Science ®Google Scholar
• Savelieva I, Camm AJ. Statins and atrial fibrillation: do we need a further study? Expert Rev Cardiovasc Ther. 2011;9(7):801–804.
   PubMedGoogle Scholar
• Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American college of cardiology/American heart association task force on practice guidelines. J Am Coll Cardiol. 2014;63(25 Pt B):2889–2934.
   PubMed Web of Science ®Google Scholar
• Djousse L, Levy D, Benjamin EJ, et al. Long-term alcohol consumption and the risk of atrial fibrillation in the Framingham Study. Am J Cardiol. 2004;93(6):710–713.
   PubMed Web of Science ®Google Scholar
• Liang Y, Mente A, Yusuf S, et al. Alcohol consumption and the risk of incident atrial fibrillation among people with cardiovascular disease. Cmaj. 2012;184(16):E857–E866.
   PubMed Web of Science ®Google Scholar
• Frost L, Vestergaard P. Alcohol and risk of atrial fibrillation or flutter: a cohort study. Arch Intern Med. 2004;164(18):1993–1998.
   PubMedGoogle Scholar
• Mukamal KJ, Tolstrup JS, Friberg J, et al. Alcohol consumption and risk of atrial fibrillation in men and women: the Copenhagen City Heart Study. Circulation. 2005;112(12):1736–1742.
   PubMed Web of Science ®Google Scholar
• Sano F, Ohira T, Kitamura A, et al. Heavy alcohol consumption and risk of atrial fibrillation. The circulatory risk in communities study (CIRCS). Circ J. 2014;78(4):955–961.
   PubMed Web of Science ®Google Scholar
• Mukamal KJ, Psaty BM, Rautaharju PM, et al. Alcohol consumption and risk and prognosis of atrial fibrillation among older adults: the cardiovascular health study. Am Heart J. 2007;153(2):260–266.
   PubMed Web of Science ®Google Scholar
• Larsson SC, Drca N, Wolk A. Alcohol consumption and risk of atrial fibrillation: a prospective study and dose-response meta-analysis. J Am Coll Cardiol. 2014;64(3):281–289.
   PubMed Web of Science ®Google Scholar
• Kodama S, Saito K, Tanaka S, et al. Alcohol consumption and risk of atrial fibrillation: a meta-analysis. J Am Coll Cardiol. 2011;57(4):427–436.
   PubMed Web of Science ®Google Scholar
• Marcus GM, Smith LM, Whiteman D, et al. Alcohol intake is significantly associated with atrial flutter in patients under 60 years of age and a shorter right atrial effective refractory period. Pacing Clin Electrophysiol. 2008;31(3):266–272.
   PubMed Web of Science ®Google Scholar
• Spaak J, Tomlinson G, McGowan CL, et al. Dose-related effects of red wine and alcohol on heart rate variability. Am J Physiol Heart Circ Physiol. 2010;298(6):H2226–H2231.
   PubMed Web of Science ®Google Scholar
• Laszlo R, Eick C, Schwiebert M, et al. Alcohol-induced electrical remodeling: effects of sustained short-term ethanol infusion on ion currents in rabbit atrium. Alcohol Clin Exp Res. 2009;33(10):1697–1703.
   PubMed Web of Science ®Google Scholar
• Overvad TF, Rasmussen LH, Skjoth F, et al. Alcohol intake and prognosis of atrial fibrillation. Heart. 2013;99(15):1093–1099.
   PubMed Web of Science ®Google Scholar
• Hart RG, Pearce LA, McBride R, et al. Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The stroke prevention in atrial fibrillation (SPAF) Investigators. Stroke. 1999;30(6):1223–1229.
   PubMed Web of Science ®Google Scholar
• Lip GYH, Frison L, Halperin JL, et al. Identifying patients at high risk for stroke despite anticoagulation: a comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort. Stroke. 2010;41(12):2731–2738.
   PubMed Web of Science ®Google Scholar
• Qiao Y, Shi R, Hou B, et al. Impact of alcohol consumption on substrate remodeling and ablation outcome of paroxysmal atrial fibrillation. J Am Heart Assoc. 2015;4(11):e002349.
   PubMed Web of Science ®Google Scholar
• Stewart S, Hart CL, Hole DJ, et al. Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/paisley study. Heart. 2001;86(5):516–521.
   PubMed Web of Science ®Google Scholar
• Krahn AD, Manfreda J, Tate RB, et al. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba follow-up study. Am J Med. 1995;98(5):476–484.
   PubMed Web of Science ®Google Scholar
• Heeringa J, Kors JA, Hofman A, et al. Cigarette smoking and risk of atrial fibrillation: the Rotterdam study. Am Heart J. 2008;156(6):1163–1169.
   PubMed Web of Science ®Google Scholar
• Chamberlain AM, Agarwal SK, Folsom AR, et al. Smoking and incidence of atrial fibrillation: results from the atherosclerosis risk in communities (ARIC) study. Heart Rhythm. 2011;8(8):1160–1166.
   PubMed Web of Science ®Google Scholar
• Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol. 2004;43(10):1731–1737.
   PubMed Web of Science ®Google Scholar
• Morris PB, Ference BA, Jahangir E, et al. Cardiovascular effects of exposure to cigarette smoke and electronic cigarettes: clinical perspectives from the prevention of cardiovascular disease section leadership council and early career councils of the American college of cardiology. J Am Coll Cardiol. 2015;66(12):1378–1391.
   PubMed Web of Science ®Google Scholar
• Albertsen IE, Rasmussen LH, Lane DA, et al. The impact of smoking on thromboembolism and mortality in patients with incident atrial fibrillation: insights from the danish diet, cancer, and health study. Chest. 2014;145(3):559–566.
   PubMed Web of Science ®Google Scholar
• Anderson L, Oldridge N, Thompson DR, et al. Exercise-based cardiac rehabilitation for coronary heart disease: Cochrane systematic review and meta-analysis. J Am Coll Cardiol. 2016;67(1):1–12.
   PubMed Web of Science ®Google Scholar
• Takeda A, Taylor SJ, Taylor RS, et al. Clinical service organisation for heart failure. Cochrane Database Syst Rev. 2012;9:CD002752.
   PubMed Web of Science ®Google Scholar
• Gyberg V, De Bacquer D, De Backer G, et al. Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the euroobservational research programme of the European society of cardiology. Cardiovasc Diabetol. 2015;14:133.
   PubMed Web of Science ®Google Scholar
• Andrikopoulos G, Tzeis S, Nikas N, et al. Short-term outcome and attainment of secondary prevention goals in patients with acute coronary syndrome–results from the countrywide TARGET study. Int J Cardiol. 2013;168(2):922–927.
   PubMed Web of Science ®Google Scholar
• Ouwens M, Wollersheim H, Hermens R, et al. Integrated care programmes for chronically ill patients: a review of systematic reviews. Int J Qual Health Care. 2005;17(2):141–146.
   PubMed Web of Science ®Google Scholar
• Martinez-Gonzalez NA, Berchtold P, Ullman K, et al. Integrated care programmes for adults with chronic conditions: a meta-review. Int J Qual Health Care. 2014;26(5):561–570.
   PubMed Web of Science ®Google Scholar
• Gillis AM, Burland L, Arnburg B, et al. Treating the right patient at the right time: an innovative approach to the management of atrial fibrillation. Can J Cardiol. 2008;24(3):195–198.
   PubMed Web of Science ®Google Scholar
• Elmouchi DA, VanOosterhout S, Muthusamy P, et al. Impact of an emergency department-initiated clinical protocol for the evaluation and treatment of atrial fibrillation. Crit Pathw Cardiol. 2014;13(2):43–48.
   PubMedGoogle Scholar
• Angaran P, Mariano Z, Dragan V, et al. The atrial fibrillation therapies after ER visit: outpatient care for patients with acute AF - The AFTER 3 study. JAFIB: Journal of Atrial Fibrillation. 2015;7(5):20–25.
   Google Scholar
• Carter L, Gardner M, Magee K, et al. An integrated management approach to atrial fibrillation. J Am Heart Assoc. 2016 Jan 25;5(1). doi:10.1161.
   PubMedGoogle Scholar
• Hendriks JM, de Wit R, Crijns HJ, et al. Nurse-led care vs. usual care for patients with atrial fibrillation: results of a randomized trial of integrated chronic care vs. routine clinical care in ambulatory patients with atrial fibrillation. Eur Heart J. 2012;33(21):2692–2699.
   PubMed Web of Science ®Google Scholar
• Hendriks J, Tomini F, van Asselt T, et al. Cost-effectiveness of a specialized atrial fibrillation clinic vs. usual care in patients with atrial fibrillation. Europace. 2013;15(8):1128–1135.
   PubMed Web of Science ®Google Scholar
• Qvist I, Hendriks JML, Møller DS, et al. Effectiveness of structured, hospital-based, nurse-led atrial fibrillation clinics: a comparison between a real-world population and a clinical trial population. Open Heart. 2016 Jan 13;3(1). doi:10.1136.
   PubMedGoogle Scholar
• Stewart S, Ball J, Horowitz JD, et al. Standard versus atrial fibrillation-specific management strategy (SAFETY) to reduce recurrent admission and prolong survival: pragmatic, multicentre, randomised controlled trial. Lancet. 2015;385(9970):775–784.
   PubMed Web of Science ®Google Scholar